Good morning. My name is Tracy, and I will be your conference operator today. I'd like to welcome everyone to the TD SYNNEX Second Quarter Fiscal 2026 Earnings Call. Today's call is being recorded.
Discusses FDA Approval and Launch Plans for Lumvoa as a New Therapy for Thyroid Eye Disease June 29, 2026 8:00 ...
Market data platform startup Databento closes $97M round after drawing $300M in investor demand - SiliconANGLE ...
Combination, if successful, would establish Noble Africa as a Nasdaq-listed, helium platform for Renergen’s Virginia Gas ProjectListing expected ...
TD Synnex (NYSE:SNX) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This content is powered by Benzinga ...
1 Respiratory Medicine, Royal Infirmary of Edinburgh and University of Edinburgh, Edinburgh, UK 2 Department of Respiratory Medicine, University Hospitals Birmingham NHS Foundation Trust (Queen ...